Evommune Inc EVMN
$11.25
▼ -0.88%
($-0.10)
📅 Earnings This Week
Open
$11.34
Prev Close
$11.35
Day Range
$10.80 – $11.37
52W Range
$10.47 – $33.20
Market Cap
$405.21M
Beta
-0.25
EPS (TTM)
$-3.87
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2025-11-06 |
| Shares Out. | 36,020,000 |
| Website | evommune.com/ ↗ |
| Phone | 13025310855 |
| Employees | 48 |
| Net Income | -$21.7M |
| Total Assets | $322.5M |
| Total Liabilities | $17.9M |
| Equity | $304.6M |
About Evommune Inc
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Evommune Inc is a publicly traded company under the ticker symbol EVMN on the NEW YORK STOCK EXCHANGE, INC., operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
17 analysts (2026-07-01)